Search

Contributor:

Rahul N. Khurana, MD

Late-Breaking Phase 3 Data From AAO Retina Subspecialty Day

Late-Breaking Phase 3 Data From AAO Retina Subspecialty Day

Glenn Jaffe, MD; and Rahul Khurana, MD

Scleral Fixation with Gore-Tex and an Akreos IOL

Scleral Fixation with Gore-Tex and an Akreos IOL

Andrew Moshfeghi, MD, Rahul Khurana, MD

Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment

Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment

Nikolas J.S. London, MD, Rahul Khurana, MD

Phase 3 CEDAR and SEQUOIA Clinical Trial Results

Phase 3 CEDAR and SEQUOIA Clinical Trial Results

Rahul N. Khurana, MD

Late-Breaking Talks at AAO '25: Phase 3 for Uveitic Macular Edema and GATHER2 OLE

Rahul Khurana, MD; and Arshad Khanani, MD, MA

AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining Reimbursement

Rahul Khurana, MD; and Paul Hahn, MD, PhD